Dermatologist Intervention Tied to Better Sun Protection

Share this content:
Dermatologist Intervention Tied to Better Sun Protection
Dermatologist Intervention Tied to Better Sun Protection

FRIDAY, Aug. 10, 2018 (HealthDay News) -- A brief intervention delivered by dermatologists is associated with improvements in patients' sun protection behavior as well as their satisfaction with dermatologists' communication, according to a study published online Aug. 8 in JAMA Dermatology.

Kimberly A. Mallett, Ph.D., from Pennsylvania State University in University Park, and colleagues examined the association of a brief dermatologist-delivered intervention in 77 patients, versus usual care in 82 patients, with patient satisfaction and sun protection behavior. The intervention took less than three minutes and consisted of six components targeting sun risk and protective behaviors. It was delivered during a skin exam or the suturing phase of skin cancer surgery.

The researchers found that patients in the intervention group rated dermatologist-patient communication more positively than did patients in the control group. Furthermore, fewer patients in the intervention group reported at least one sunburn one month after the intervention versus usual care patients (18 versus 35 percent). However, at three-month follow-up there were no differences in reported sunburns. At three months, patients in the intervention group reported increased use of sunscreen compared with the usual care patients (face: intervention increased 12 percent and control decreased 4 percent; body: intervention increased 12 percent and control decreased 1 percent; reapplication: intervention increased 15 percent and control remained stable).

"The study provided evidence that a brief (<3 minutes) dermatologist-delivered intervention was associated with patients' sun protection behavior across several months," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »